$BLPG
Blue Line Protection Group, Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224044371 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.023M
YoY Change -7.48%
Cost Of Revenue $406.0K
YoY Change 4.41%
Gross Profit $617.2K
YoY Change -13.93%
Gross Profit Margin 60.32%
Selling, General & Admin $616.7K
YoY Change 23.35%
% of Gross Profit 99.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $19.22K
YoY Change -28.72%
% of Gross Profit 3.11%
Operating Expenses $616.7K
YoY Change 24.36%
Operating Profit $466.00
YoY Change -99.79%
Interest Expense $78.81K
YoY Change 75.42%
% of Operating Profit 16912.02%
Other Income/Expense, Net $78.81K
YoY Change -607.54%
Pretax Income $79.28K
YoY Change -62.25%
Income Tax
% Of Pretax Income
Net Earnings $79.28K
YoY Change -61.45%
Net Earnings / Revenue 7.75%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.01
COMMON SHARES
Basic Shares Outstanding 8.250M shares 8.250M shares
Diluted Shares Outstanding 15.31M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $848.4K
YoY Change 66.35%
Cash & Equivalents $848.4K
Short-Term Investments
Other Short-Term Assets $34.40K
YoY Change 14.67%
Inventory
Prepaid Expenses
Receivables $307.8K
Other Receivables $0.00
Total Short-Term Assets $1.191M
YoY Change 30.77%
LONG-TERM ASSETS
Property, Plant & Equipment $200.1K
YoY Change -77.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $31.74K
YoY Change 5.8%
Total Long-Term Assets $707.9K
YoY Change -22.97%
TOTAL ASSETS
Total Short-Term Assets $1.191M
Total Long-Term Assets $707.9K
Total Assets $1.899M
YoY Change 3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $616.5K
YoY Change -6.59%
Accrued Expenses $171.7K
YoY Change 7.29%
Deferred Revenue
YoY Change
Short-Term Debt $791.3K
YoY Change 14.68%
Long-Term Debt Due $19.76K
YoY Change -1.2%
Total Short-Term Liabilities $2.180M
YoY Change 12.93%
LONG-TERM LIABILITIES
Long-Term Debt $596.5K
YoY Change -29.82%
Other Long-Term Liabilities $331.8K
YoY Change -32.29%
Total Long-Term Liabilities $928.3K
YoY Change -31.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.180M
Total Long-Term Liabilities $928.3K
Total Liabilities $3.108M
YoY Change -5.12%
SHAREHOLDERS EQUITY
Retained Earnings -$11.51M
YoY Change -1.07%
Common Stock $8.251K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.209M
YoY Change
Total Liabilities & Shareholders Equity $1.899M
YoY Change 3.77%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $79.28K
YoY Change -61.45%
Depreciation, Depletion And Amortization $19.22K
YoY Change -28.72%
Cash From Operating Activities $66.85K
YoY Change -76.95%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.13K
YoY Change -49.84%
NET CHANGE
Cash From Operating Activities 66.85K
Cash From Investing Activities 0.000
Cash From Financing Activities -40.13K
Net Change In Cash 26.72K
YoY Change -75.71%
FREE CASH FLOW
Cash From Operating Activities $66.85K
Capital Expenditures $0.00
Free Cash Flow $66.85K
YoY Change -64.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
848407 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34398 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1190636 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
476076 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
616508 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
19760 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
638500 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
171663 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
580352 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2179554 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
331757 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
928291 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3107845 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
200 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
8251 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10292363 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11510122 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1898550 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1023208 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001416697
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Address Address Line1
EntityAddressAddressLine1
5765 Logan St.
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80216
dei City Area Code
CityAreaCode
(800)
dei Local Phone Number
LocalPhoneNumber
844-5576
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8250144 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
585780 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
368352 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34174 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
988306 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
586620 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200096 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
254171 usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2024Q3 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
678954 usd
CY2023Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
843573 usd
CY2024Q3 us-gaap Security Deposit
SecurityDeposit
28960 usd
CY2023Q4 us-gaap Assets
Assets
1860839 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
511622 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
22022 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
638500 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
121519 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
503584 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1950018 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
15545 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
494215 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1283749 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3233767 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
20000000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
200 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8250144 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8250144 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8250144 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8250144 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8251 usd
CY2024Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
129 shares
CY2023Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
129 shares
CY2023Q4 BLPG Common Stock Owed But Not Issued
CommonStockOwedButNotIssued
13 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10233185 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11614577 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1209295 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1372928 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1860839 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1105945 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3308986 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3219512 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
406004 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
388852 usd
us-gaap Cost Of Revenue
CostOfRevenue
1201967 usd
us-gaap Cost Of Revenue
CostOfRevenue
1117431 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
717093 usd
us-gaap Gross Profit
GrossProfit
2107019 usd
us-gaap Gross Profit
GrossProfit
2102081 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
616738 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
495919 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1760479 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1607904 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
616738 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
495919 usd
us-gaap Operating Expenses
OperatingExpenses
1760479 usd
us-gaap Operating Expenses
OperatingExpenses
1607904 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
466 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
221174 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
346540 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
494177 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
BLPG Initial Recognition Of Right Of Use Asset And Lease Liability
InitialRecognitionOfRightOfUseAssetAndLeaseLiability
usd
CY2024Q3 BLPG Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52942
dei Entity Registrant Name
EntityRegistrantName
BLUE LINE PROTECTION GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5543728
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
307831 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
28960 usd
CY2024Q3 us-gaap Assets
Assets
1898550 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2024Q3 BLPG Common Stock Owed But Not Issued
CommonStockOwedButNotIssued
13 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
617204 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1000 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
1210 usd
us-gaap Interest Income Other
InterestIncomeOther
1210 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
46190 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
44927 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
143679 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
143861 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
123791 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
28399 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-99616 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-20320 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
78811 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15528 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-242085 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-163181 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
79277 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
205646 usd
us-gaap Net Income Loss
NetIncomeLoss
104455 usd
us-gaap Net Income Loss
NetIncomeLoss
330996 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15305508 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17474060 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15305508 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17474060 shares
us-gaap Net Income Loss
NetIncomeLoss
104455 usd
us-gaap Net Income Loss
NetIncomeLoss
330996 usd
us-gaap Depreciation
Depreciation
61100 usd
us-gaap Depreciation
Depreciation
95372 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
110544 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
99748 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
36330 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
37590 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
99616 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
20320 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-60521 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11016 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
224 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2048 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
104887 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
107301 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-112314 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-102085 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
464915 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
598210 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7025 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
104193 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7025 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104193 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
64392 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
177455 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
168820 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
17808 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
26183 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195263 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-259395 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
262627 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
234622 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
585780 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
280073 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
848407 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
514695 usd
us-gaap Interest Paid Net
InterestPaidNet
99884 usd
us-gaap Interest Paid Net
InterestPaidNet
58799 usd
BLPG Derivative Resolution
DerivativeResolution
22848 usd
BLPG Derivative Resolution
DerivativeResolution
76682 usd
BLPG Initial Recognition Of Right Of Use Asset And Lease Liability
InitialRecognitionOfRightOfUseAssetAndLeaseLiability
312432 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1695796 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14431 usd
CY2023Q3 BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
29589 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
205646 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1446130 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1297508 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8936 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
79277 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1209295 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1891398 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37590 usd
BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
76682 usd
us-gaap Net Income Loss
NetIncomeLoss
330996 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1446130 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1372928 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1372928 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36330 usd
BLPG Adjustments To Additional Paid In Capital Derivative Resolution
AdjustmentsToAdditionalPaidInCapitalDerivativeResolution
22848 usd
us-gaap Net Income Loss
NetIncomeLoss
104455 usd
us-gaap Net Income Loss
NetIncomeLoss
104455 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1209295 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1209295 usd
CY2006Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2006Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On May 6, 2014, the Company effected a forward stock split and a pro-rata increase in its authorized common stock on a basis of 14-to-1, whereby each shareholder received 14 newly issued shares of common stock for each 1 share held.
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000 shares
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-100
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_z8UzuMvr6a0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zlZVc2fzNZeb">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
178229 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2024Q3 us-gaap Depreciation
Depreciation
19217 usd
us-gaap Depreciation
Depreciation
61100 usd
CY2023Q3 us-gaap Depreciation
Depreciation
38767 usd
us-gaap Depreciation
Depreciation
95372 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zPF4up1LP5sc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zcLX8kacEYAb">Concentration of business and credit risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has no significant off-balance sheet risks such as foreign exchange contracts, option contracts or other hedging arrangements. The Company’s financial instruments that are exposed to concentration of credit risks consist primarily of cash. The Company maintains its cash in bank accounts, which may at times, exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__srt--MajorCustomersAxis__custom--OneMajorCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zJd9W2GVqnWa" title="Concentration credit risk, percentage">10</span>% of total revenue for the nine months ended September 30, 2024 and one customer comprised <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240101__20240930__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbFIWN9AH5fj" title="Concentration credit risk, percentage">16</span>% of the account receivable balance at September 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--OneMajorCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zlp0V7djU5ga" title="Concentration credit risk, percentage">10</span>% of total revenue for the nine months ended September 30, 2023 and one customer comprised <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5kritkTqlB2" title="Concentration credit risk, percentage">17</span>% of the account receivable balance at September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
580352 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
580352 usd
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
503584 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
503584 usd
CY2024Q3 us-gaap Revenues
Revenues
1023208 usd
CY2023Q3 us-gaap Revenues
Revenues
1105945 usd
us-gaap Revenues
Revenues
3308986 usd
us-gaap Revenues
Revenues
3219512 usd
CY2024Q3 us-gaap Advertising Expense
AdvertisingExpense
482 usd
us-gaap Advertising Expense
AdvertisingExpense
730 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
79277 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
205646 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
7055364 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
9223916 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15305508 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17474060 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Net Income Loss
NetIncomeLoss
104455 usd
us-gaap Net Income Loss
NetIncomeLoss
330996 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8250144 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
7055364 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
9223916 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15305508 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17474060 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
34346 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
34346 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
55499 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
224230 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
193112 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
88179 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
37197 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
598217 usd
CY2024Q3 BLPG Operating Right Of Use Assets Lease
OperatingRightOfUseAssetsLease
476076 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
476076 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
171663 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
331757 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
503420 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P36Y3M
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
110544 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
51019 usd
BLPG Finance Lease Expense
FinanceLeaseExpense
161563 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
163355 usd
CY2023Q4 BLPG Operating Right Of Use Assets Lease
OperatingRightOfUseAssetsLease
586620 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
586620 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
121519 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
494215 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
615734 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P42Y6M
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
134428 usd
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
67184 usd
CY2023 BLPG Finance Lease Expense
FinanceLeaseExpense
201612 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
137064 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1037376 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1030351 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
837280 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
776180 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200096 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
254171 usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
2782 usd
CY2024Q3 us-gaap Depreciation
Depreciation
19217 usd
us-gaap Depreciation
Depreciation
61100 usd
CY2023Q3 us-gaap Depreciation
Depreciation
38767 usd
us-gaap Depreciation
Depreciation
95372 usd
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
137500 usd
CY2022Q1 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
12500 usd
CY2022Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
137500 usd
CY2022Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2022Q3 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
250000 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2022Q3 BLPG Default Rate Percentage
DefaultRatePercentage
0.12 pure
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
503584 usd
us-gaap Derivative Fair Value Hedge Included In Effectiveness Gain Loss
DerivativeFairValueHedgeIncludedInEffectivenessGainLoss
99616 usd
BLPG Settlement Of Derivatives Upon Repayment
SettlementOfDerivativesUponRepayment
-22848 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
580352 usd
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2014Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On May 6, 2014, the Company effected a forward stock split and a pro-rata increase in its authorized common stock on a basis of 14-to-1, whereby each shareholder received 14 newly issued shares of common stock for each 1 share held.
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1400000000 shares
CY2021Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On July 6, 2021, the Company effected a reverse stock split and a pro-rata decrease in its authorized common stock on a basis of 1-for-100, the authorized capital of the Company concurrently decreased to 14,000,000 shares of common stock.
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14000000 shares
CY2021Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
1570 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3332000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
35000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.21
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3297000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.21
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1713500 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.21
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.21
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3297000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y6M
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.21
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1713500 shares
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.21
us-gaap Share Based Compensation
ShareBasedCompensation
36330 usd
us-gaap Share Based Compensation
ShareBasedCompensation
37950 usd

Files In Submission

Name View Source Status
blpg-20240930_def.xml Edgar Link unprocessable
0001493152-24-044371-index-headers.html Edgar Link pending
0001493152-24-044371-index.html Edgar Link pending
0001493152-24-044371.txt Edgar Link pending
0001493152-24-044371-xbrl.zip Edgar Link pending
blpg-20240930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
blpg-20240930_cal.xml Edgar Link unprocessable
blpg-20240930_lab.xml Edgar Link unprocessable
blpg-20240930_pre.xml Edgar Link unprocessable
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable